immunoglobin A nephropathy

Alnylam clears phase 2 test for Regeneron-partnered nephropathy med, as it looks to play catch-up against Calliditas
Fierce Biotech
Tue, 08/30/22 - 11:48 am
Alnylam
Regeneron
Calliditas
immunoglobin A nephropathy
clinical trials
Ionis hands off an antisense drug for kidney disease, giving all rights to Roche
Endpoints
Mon, 07/11/22 - 06:23 pm
Ionis Pharmaceuticals
Roche
IONIS-FB-LRx
clinical trials
immunoglobin A nephropathy
kidney disease
Startup targets orphan kidney disease with former Merck drug
MedCity News
Tue, 01/26/21 - 11:10 am
Vera Therapeutics
Merck
funding
kidney disease
immunoglobin A nephropathy
atacicept